Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Septerna, Inc.

Market Cap 1.62B 1.4B 1.29B 1.21B 2.27B 153B 2.29B 15.2B 5.94B 75B 6.08B 5.95B 260B P/E Ratio 2026 *
-20.9x
P/E Ratio 2027 * -15x
Enterprise Value 1.27B 1.1B 1.01B 946M 1.78B 120B 1.8B 11.92B 4.66B 58.85B 4.77B 4.67B 204B EV / Sales 2026 *
16.5x
EV / Sales 2027 * 16.9x
Free-Float
97.17%
Yield 2026 *
-
Yield 2027 * -
1 day+1.43%
1 week+20.09%
Current month+20.93%
1 month+35.51%
3 months+45.27%
6 months+34.36%
Current year+30.99%
1 week 30.24
Extreme 30.235
37.01
1 month 25.79
Extreme 25.79
37.01
Current year 22.78
Extreme 22.78
37.01
1 year 9.85
Extreme 9.8515
37.01
3 years 4.17
Extreme 4.17
37.01
5 years 4.17
Extreme 4.17
37.01
10 years 4.17
Extreme 4.17
37.01
Manager TitleAgeSince
Chief Executive Officer 60 2021-10-31
President 58 2025-07-31
Director of Finance/CFO 55 2025-01-05
Director TitleAgeSince
Chairman 50 2021-10-31
Director/Board Member 51 2023-12-31
Director/Board Member 60 2023-11-30
Date Insider Type Main position Quantity % Market Cap.
05-31Fiscal year

Head of Human Resources

17,805 0.0395%
05-25Fiscal year

Head of Human Resources

35,394 0.0788%
04-14Fiscal year

Chairperson

12,000 0.0267%
Change 5-day change 1-year change 3-year change Capi.($)
+0.96%+20.09%+246.49% - 1.62B
+0.96%+1.16%-12.70%-12.33% 43.03B
+3.78%+7.60%+301.76%+535.56% 32.71B
-2.06%-3.66%+11.13%-18.36% 30.29B
+0.88%-1.81%+0.56%+32.27% 29.4B
+1.16%+2.10%+14.27%+22.05% 25.08B
+2.62%+8.47% - - 13.54B
+0.03%+1.69%+54.70%+111.06% 13.35B
-1.09%-2.31%+3.49%+5.00% 12.97B
+0.44%+0.12%+108.94%+76.61% 12.11B
Average +0.67%+2.29%+80.96%+93.98% 21.41B
Weighted average by Cap. +0.71%+0.93%+62.48%+102.60%

Financials

2026 *2027 *
Net sales 76.94M 66.32M 61.03M 57.26M 108M 7.27B 109M 722M 282M 3.56B 289M 283M 12.32B 65.86M 56.77M 52.25M 49.01M 92.07M 6.22B 92.99M 618M 241M 3.05B 247M 242M 10.55B
Net income -76.38M -65.83M -60.59M -56.84M -107M -7.22B -108M -716M -280M -3.54B -287M -281M -12.23B -121M -104M -96.04M -90.1M -169M -11.44B -171M -1.14B -443M -5.6B -454M -445M -19.39B
Net Debt -349M -301M -277M -260M -488M -32.97B -493M -3.27B -1.28B -16.15B -1.31B -1.28B -55.88B -508M -438M -403M -378M -711M -48.05B -718M -4.77B -1.86B -23.53B -1.91B -1.87B -81.43B
Logo Septerna, Inc.
Septerna, Inc. is a clinical-stage biotechnology company. The Company is developing G protein-coupled receptor (GPCR) oral small-molecule drug discovery powered by its proprietary Native Complex Platform. Its pipeline of product candidates is focused on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. Its industrial-scale Native Complex Platform is designed to target certain GPCRs for the first time, uncover novel binding pockets for validated receptors, and pursue a wide spectrum of pharmacologies, including agonists, antagonists, and allosteric modulators, to achieve desired therapeutic effects. It is advancing a deep portfolio of oral small molecule GPCR-targeted programs with novel mechanistic approaches to treat diseases across multiple therapeutic areas for patients with unmet needs. It is focused on therapeutic areas, such as neurology, women’s health, cardiovascular, and respiratory disease.
Employees
130
Date Price Change Volume
26-06-15 36.44 $ +1.38% 144,408
26-06-12 35.95 $ +5.64% 475,864
26-06-11 34.03 $ +11.68% 513,326
26-06-10 30.47 $ -1.74% 171,877
26-06-09 31.01 $ +1.97% 277,830
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
35.95USD
Average target price
45.78USD
Spread / Average Target
+27.34%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SEPN Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!